Dolby Laboratories (NYSE:DLB) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Dolby Laboratories logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Dolby Laboratories beat quarterly earnings expectations, reporting EPS of $1.25 versus the $1.20 consensus and revenue of $373.54 million, slightly above analysts’ $372.76 million estimate.
  • The company guided for Q1 2027 EPS of $0.41–$0.56 and full-year 2027 EPS of $4.27–$4.42. Its shares fell 4.2% during Tuesday trading.
  • Analysts’ consensus rating was Moderate Buy, with an $85 average price target; Dolby also has a $350 million share-repurchase authorization, covering up to 7% of shares.
  • Interested in Dolby Laboratories? Here are five stocks we like better.

Dolby Laboratories (NYSE:DLB - Get Free Report) issued its quarterly earnings data on Tuesday. The electronics maker reported $1.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.20 by $0.05, FiscalAI reports. The company had revenue of $373.54 million during the quarter, compared to analysts' expectations of $372.76 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. Dolby Laboratories updated its Q1 2027 guidance to 0.410-0.560 EPS and its FY 2027 guidance to 4.270-4.420 EPS.

Dolby Laboratories Trading Down 4.2%

Shares of NYSE:DLB traded down $2.56 during midday trading on Tuesday, reaching $58.60. The company had a trading volume of 3,929,316 shares, compared to its average volume of 841,243. The stock has a market cap of $5.49 billion, a P/E ratio of 24.94 and a beta of 0.79. Dolby Laboratories has a 52-week low of $48.26 and a 52-week high of $69.95. The company's 50 day moving average price is $60.97 and its 200 day moving average price is $59.43.

Insider Buying and Selling

In other news, SVP John D. Couling sold 7,667 shares of the business's stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the sale, the senior vice president owned 166,803 shares of the company's stock, valued at $9,804,680.34. The trade was a 4.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Ryan Nicholson sold 1,183 shares of the firm's stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the sale, the chief accounting officer directly owned 34,453 shares in the company, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,517 shares of company stock worth $995,963 in the last ninety days. 37.93% of the stock is currently owned by insiders.

Dolby Laboratories News Summary

These are some of the DLB news items that stood out recently:

  • Positive Sentiment: Zacks Research made small upward revisions to several 2027–2028 EPS estimates, including its FY2028 forecast to $3.40 from $3.38, though it maintained a Hold rating.
  • Neutral Sentiment: Trading volume was substantially above its average, suggesting heightened investor activity around the earnings release; the reports do not establish what drove the market’s reaction.
  • Negative Sentiment: Rosenblatt Securities cut its price target to $80 from $85. It retained a Buy rating, so the revision was a less-bullish valuation view rather than a downgrade.

Wall Street Analyst Weigh In

DLB has been the topic of a number of analyst reports. Zacks Research upgraded shares of Dolby Laboratories from a "strong sell" rating to a "hold" rating in a research note on Friday. Wall Street Zen lowered shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Rosenblatt Securities decreased their price target on shares of Dolby Laboratories from $85.00 to $80.00 and set a "buy" rating for the company in a research report on Monday. Finally, Weiss Ratings upgraded shares of Dolby Laboratories from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, September 9th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $85.00.

Read Our Latest Analysis on DLB

Dolby Laboratories announced that its Board of Directors has approved a share buyback program on Thursday, July 30th that allows the company to buy back $350 million in shares. This buyback authorization allows the electronics maker to purchase up to 7% of its shares through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Featured Stories

Earnings History for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines